Market Overview

Leerink Lifts Target On Align Technology, Sees 27% Upside

Share:
Leerink Lifts Target On Align Technology, Sees 27% Upside
Related ALGN
When Bull Markets Die: What To Watch For, What Stocks Could Be The First To Get Hit
Inside Align Technology's Q2 Beat And Raise: Teen Segment Could See An Inflection Point
Stocks To Watch With Next EPS Report On Tap: Merit Medical Systems (Investor's Business Daily)

After a nearly 60-percent return since the start of 2017, analysts at Leerink see further upside in shares of Align Technology, Inc.
(NASDAQ: ALGN), a marketer and seller of digital services used in dentistry, orthodontics and dental records storage.

Leerink's Richard Newitter maintains a Buy rating on Allign's stock with a price target boosted from $149 to $194 after hosting a conference call with two specialists to discuss the company's Invisalign product which is a clear alternative to metal braces for adults and teens. One of the orthodontists is a West Coast-based high-volume Invisalign user who performed 400 case starts in 2016 and the other is an East Coast-based orthodontist with 100 case starts in 2016.

tipranks.png

Both experts are expecting an increase in Invisalign case starts of 20–25 percent year over year, and patient volumes have been "healthy" since the start of the year, Newitter noted. Both specialists also indicate they will be increasing the adoption of Invisalign over the next one to two years as quickly as possible, albeit from different starting points.

The West Coast orthodontist also stated that more than 60 percent of all patients opted for the Invisalign product over the past 12 months, which marks an increase from around 35–40 percent in the prior year. The orthodontist is now targeting an adoption rate of 80 percent over the next year and is in fact charging more for traditional braces to incentivize patients toward Invisalign.

Bottom line, the feedback received from the two specialists merely reinforces the analyst's already bullish stance but adds further conviction that utilization rates can continue to accelerate within the large and underpenetrated North American aligner market.

Related Links:

Align's New Direct-To-Consumer Focus Earns It A Higher Price Target From Stifel

5 Stocks To Watch For June 27, 2017
______
Image Credit: By Davisdentalcare (Own work) [CC BY-SA 4.0 (http://creativecommons.org/licenses/by-sa/4.0)], via Wikimedia Commons

Latest Ratings for ALGN

DateFirmActionFromTo
Oct 2017Morgan StanleyMaintainsOverweight
Jul 2017Leerink SwannMaintainsOutperform
Jul 2017Bank of AmericaUpgradesNeutralBuy

View More Analyst Ratings for ALGN
View the Latest Analyst Ratings

Posted-In: Align Technology braces Invisalign LeerinkAnalyst Color Health Care Analyst Ratings General

 

Related Articles (ALGN)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...